Market closed

Cronos Group/$CRON

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Cronos Group

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Ticker

$CRON
Trading on

Industry

Pharmaceuticals

Headquarters

Toronto, Canada

Employees

356

Cronos Group Metrics

BasicAdvanced
$733M
Market cap
-
P/E ratio
-$0.12
EPS
1.01
Beta
-
Dividend rate
$733M
1.01
$3.14
$1.86
1.3M
24.244
22.632
0.077
0.164
-3.14%
-4.37%
6.624
0.96
1
44.12
30.31%
-56.68%
19.19%
-50.43%

What the Analysts think about Cronos Group

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Cronos Group stock.

Cronos Group Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Cronos Group Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CRON

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Cronos Group stock?

Cronos Group (CRON) has a market cap of $733M as of December 15, 2024.

What is the P/E ratio for Cronos Group stock?

The price to earnings (P/E) ratio for Cronos Group (CRON) stock is 0 as of December 15, 2024.

Does Cronos Group stock pay dividends?

No, Cronos Group (CRON) stock does not pay dividends to its shareholders as of December 15, 2024.

When is the next Cronos Group dividend payment date?

Cronos Group (CRON) stock does not pay dividends to its shareholders.

What is the beta indicator for Cronos Group?

Cronos Group (CRON) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.